Skip to main content
Tech.euFundingExplorerBeta

Azura Ophthalmics

Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD.

Azura Ophthalmics has raised €17M across 1 funding round from 4 investors, most recently a Series C round in Oct 2020. Based in Tel Aviv, Israel; founded 2014; active in Healthtech. Data as of 28 Oct 2026.

Tel Aviv, IsraelFounded 2014azuraophthalmics.com ↗
Healthtech
← All companies
Total raised
€17M
€16,869,096
Funding rounds
1
Investors
4
distinct backers
Active since
2020-10
latest 2020-10

Funding by year

EUR raised per year
Azura Ophthalmics — funding by year — interactive chart.
Data table
Azura Ophthalmics — funding by year
2020€17M

Signals

High confidence
Raise-next likelihood9
base rate 50% for Series C
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2020-10-26Series C€17MGanot Capital,Medical Research Commercialisation Fund (MRCF),OrbiMed,TPG BiotechView deal →

Investors

4
Ganot CapitalMedical Research Commercialisation Fund (MRCF)OrbiMedTPG Biotech

Related news

Similar companies

same sector or country

Global coverage: FundingData